Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asperum: Acetylsalicylic Acid in COVID-19 Pneumonia
NCT04808895Phase 3Unknown
- Sponsor
- Azienda Ospedaliera Universitaria Integrata Verona
- Start
- Apr 2021
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in coronavirus disease 2019 (COVID-19), pulmonary embolism (PE), sponsored by Azienda Ospedaliera Universitaria Integrata Verona. Status: unknown.
02
Drugs
aspirin
03
Conditions
coronavirus disease 2019 (COVID-19)pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT04808895.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04808895.